Skip to main content
OpenTrials

Clinical trial condition

KRAS Activating Mutation

Explore clinical trials studying KRAS Activating Mutation. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

KRAS Activating Mutation trial results

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • UCSF Thoracic Oncology San Francisco, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavllion Aurora, Colorado, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 45 locations
Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Rocky Mountain Cancer Center, LLP Boulder, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center, MedStar Georgetown Cancer Institute, Washington D.C., District of Columbia, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
View all 35 locations
Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +14 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States